COMMUNIQUÉS West-GlobeNewswire

-
Progenics Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
25/04/2018 - 23:00 -
R1 RCM to Release First Quarter 2018 Results on May 9
25/04/2018 - 23:00 -
Dentsply Sirona to Host First Quarter 2018 Conference Call on May 7th
25/04/2018 - 23:00 -
Osiris Announces New Peer-Reviewed Publication Summarizing Clinical Outcomes of Viable Cryopreserved Placental Membranes for Management of Chronic Diabetic Foot Ulcers in Real World Setting
25/04/2018 - 22:30 -
BeyondSpring to Present Neutropenia Clinical Trial Data on Lead Asset, Plinabulin, at 2018 ASCO Annual Meeting
25/04/2018 - 22:30 -
FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary
25/04/2018 - 22:30 -
Dyadic International to Announce First Quarter 2018 Financial Results and Host Conference Call on Thursday May 10, 2018
25/04/2018 - 22:30 -
Vital Therapies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25/04/2018 - 22:30 -
Burcon Announces Delisting From Nasdaq Capital Market
25/04/2018 - 22:22 -
Golden Leaf Holdings Appoints Rick Miller to Board of Directors
25/04/2018 - 22:05 -
Conatus Pharmaceuticals to Report First Quarter 2018 Financial Results
25/04/2018 - 22:05 -
Marrone Bio Innovations and Lidorr Chemicals Ltd. Sign Distribution Agreement in Israel
25/04/2018 - 22:05 -
BioTelemetry, Inc. Reports First Quarter 2018 Financial Results
25/04/2018 - 22:05 -
LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)
25/04/2018 - 22:05 -
PRA Health Sciences Announces Retirement of Chief Financial Officer and Promotion of Michael Bonello to CFO
25/04/2018 - 22:04 -
Ossur Hf : Updated financial calendar for the financial year 2018
25/04/2018 - 22:03 -
Calithera Biosciences Announces CB-839 Abstracts Accepted for Presentation at ASCO 2018
25/04/2018 - 22:03 -
Galapagos reports first quarter 2018 results
25/04/2018 - 22:02 -
Ossur Hf : Interim report Q1 2018
25/04/2018 - 22:01
Pages